webinar
Oct. 27-28, 2025, Boston, MA, USA - Booth 114.
Read More

Fmoc-N-amido-PEG6-propionic acid

  CAS No.: 882847-34-9   Cat No.: BADC-01185   Purity: ≥95% 4.5  

Fmoc-N-amido-PEG6-propionic acid provides a medium-length PEG linker with Fmoc protection, improving flexibility, solubility, and antibody conjugation efficiency. It is suitable for stable, targeted delivery in antibody-drug conjugate therapeutics.

Fmoc-N-amido-PEG6-propionic acid

Structure of 882847-34-9

Quality
Assurance

Worldwide
Delivery

24/7 Customer
Support
Category
ADC Linker
Molecular Formula
C30H41NO10
Molecular Weight
575.65
Shipping
Room temperature
Shipping
Store at 2-8°C

* For research and manufacturing use only. We do not sell to patients.

Size Price Stock Quantity
-- $-- In stock

Looking for different specifications? Click to request a custom quote!

Capabilities & Facilities

Popular Publications Citing BOC Sciences Products
Synonyms
Fmoc-N-amido-PEG6-acid; Fmoc-21-amino-4,7,10,13,16,19-hexaoxaheneicosanoic acid; 5,8,11,14,17,20-Hexaoxa-2-azatricosanedioic acid, 1-(9H-fluoren-9-ylmethyl) ester; Fmoc-NH-PEG6-CH2CH2COOH; 1-(9H-Fluoren-9-yl)-3-oxo-2,7,10,13,16,19,22-heptaoxa-4-azapentacosan-25-oic acid; (Fmoc-amino)-PEG6-carboxylic Acid; 21-(Fmoc-amino)-4,7,10,13,16,19-hexaoxahenicosanoic Acid; 21-[(9H-Fluoren-9-ylmethoxy)carbonylamino]-4,7,10,13,16,19-hexaoxahenicosanoic Acid
IUPAC Name
3-[2-[2-[2-[2-[2-[2-(9H-fluoren-9-ylmethoxycarbonylamino)ethoxy]ethoxy]ethoxy]ethoxy]ethoxy]ethoxy]propanoic acid
Canonical SMILES
C1=CC=C2C(=C1)C(C3=CC=CC=C32)COC(=O)NCCOCCOCCOCCOCCOCCOCCC(=O)O
InChI
InChI=1S/C30H41NO10/c32-29(33)9-11-35-13-15-37-17-19-39-21-22-40-20-18-38-16-14-36-12-10-31-30(34)41-23-28-26-7-3-1-5-24(26)25-6-2-4-8-27(25)28/h1-8,28H,9-23H2,(H,31,34)(H,32,33)
InChIKey
HEGZERUHBVYZPH-UHFFFAOYSA-N
Density
1.202±0.06 g/cm3 at 20°C, 760 Torr
Solubility
Soluble in DMSO (Slightly), Methanol (Slightly)
PSA
131.01000
Appearance
Colorless to light yellow clear liquid
Shipping
Room temperature
Storage
Store at 2-8°C
Pictograms
Irritant
Signal Word
Warning
Boiling Point
734.8±60.0 °C at 760 mmHg
Biological Activity
Fmoc-NH-PEG6-CH2CH2COOH is a cleavable ADC linker used in the synthesis of antibody-drug conjugates (ADCs)[1] . In Vitro: ADCs are comprised of an antibody to which is attached an ADC cytotoxin through an ADC linker.

Fmoc-N-amido-PEG6-propionic acid is a bifunctional linker widely used in peptide and protein chemistry. Here are some key applications of Fmoc-N-amido-PEG6-propionic acid:

Peptide Synthesis: Fmoc-N-amido-PEG6-propionic acid is used as a spacer in solid-phase peptide synthesis (SPPS) to introduce flexibility between peptide chains. The PEG6 moiety provides hydrophilicity and helps in solubilizing peptide sequences. This can improve the overall yield and purity of synthesized peptides, especially those prone to aggregation.

Drug Delivery Systems: This compound is employed in the design of advanced drug delivery systems, where the PEG6 linker helps in modulating the pharmacokinetics of the drug. By attaching to therapeutic molecules, the PEG6 spacer can enhance solubility, reduce immunogenicity, and increase the circulation time in the bloodstream. This can lead to more effective and sustained drug release profiles.

Bioconjugation: Fmoc-N-amido-PEG6-propionic acid is instrumental in bioconjugation techniques used to link peptides or proteins to other biomolecules or surfaces. The PEG6 linker acts as a flexible bridge that can reduce steric hindrance and maintain the biological activity of conjugated molecules. This is especially useful in the development of biosensors, imaging agents, and therapeutic conjugates.

Protein Engineering: In protein engineering, this linker is used to modify and stabilize proteins by attaching functional groups or polymers. The PEG6 spacer can enhance protein solubility and stability under various conditions, thus extending their shelf-life and functionality. This application is crucial for producing high-quality proteins for research, diagnostics, and therapeutic purposes.

The molarity calculator equation

Mass (g) = Concentration (mol/L) × Volume (L) × Molecular Weight (g/mol)

The dilution calculator equation

Concentration (start) × Volume (start) = Concentration (final) × Volume (final)

This equation is commonly abbreviated as: C1V1 = C2V2

Related Products

Contact our experts today for pricing and comprehensive details on our ADC offerings.

You May Also Be Interested In

From cytotoxin synthesis to linker design, discover our specialized services that complement your ADC projects.

ADC Linker Development Enzyme Cleavable Linker Cathepsin B Cleavable Linker/Peptide Linker Phosphatase Cleavable Linker β-Glucuronide Linker β-Galactosidase Cleavable Linker Sulfatase Cleavable Linker Chemically Cleavable Linker Non-Cleavable Linker Services Acid Cleavable Linker/Hydrazone Linker

Unlock Deeper ADC Insights

Learn more about payload design, linker strategies, and integrated CDMO support through our curated ADC content.

Linkers - A Crucial Factor in Antibody–Drug Conjugates In-Depth Review of ADC Linkers: Types, Mechanisms, and Research Progress New Structural Insights Solve Instability Issues of Maleimide Linkers in ADCs PEG Linkers in Antibody-Drug Conjugates Peptide Linkers in Antibody-Drug Conjugates Disulfide Linkers in Antibody-Drug Conjugates Biotinylation Reagents in Antibody-Drug Conjugates Maleimide Linkers in Antibody-Drug Conjugates Current ADC Linker Chemistry SPDB Linkers in Antibody-Drug Conjugates

Explore More ADC Products

Find exactly what your project needs from our expanded range of ADCs, offering flexible options to fit your timelines and goals.

ADC Cytotoxin

Powerful Targeted Cancer Solutions

ADC  Cytotoxin with Linker

Enhanced Stability And Efficacy

ADC Linker

Precise Conjugation For Success

Antibody-Drug  Conjugates (ADCs)

Maximized Therapeutic Performance

Auristatins

Next-Level Tubulin Inhibition

Calicheamicins

High-Impact DNA Targeting

Camptothecins

Advanced Topoisomerase Inhibition

Daunorubicins / Doxorubicins

Trusted Anthracycline Payloads

Duocarmycins

Potent DNA Alkylation Agents

Maytansinoids

Superior Microtubule Disruption

Pyrrolobenzodiazepines

Ultra-Potent DNA Crosslinkers

Traditional Cytotoxic Agents

Proven Chemotherapy Solutions

Cleavable Linker

Precise Intracellular Drug Release

Non-Cleavable Linker

Exceptional Long-Term Stability

Historical Records: DC-1 | (2,5-dioxopyrrolidin-1-yl) 3-[2-[2-[2-[2-(2-hydroxyethoxy)ethoxy]ethoxy]ethoxy]ethoxy]propanoate | (2,5-dioxopyrrolidin-1-yl) 4-(methyldisulfanyl)pentanoate | (2,5-dioxopyrrolidin-1-yl) 4-methyl-4-(methyldisulfanyl)pentanoate | (2,5-dioxopyrrolidin-1-yl) 4-(methyldisulfanyl)butanoate | Biotin-PEG4-PFP ester | Zilovertamab vedotin | CL2A-Chimmitecan | Fmoc-N-amido-PEG2-propionic acid | MC-VC-PABC-MMAE | Fmoc-N-amido-PEG3-propionic acid
Send Inquiry
Verification code
Inquiry Basket